Literature DB >> 17335789

Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.

Jean Kyung Paik1, Oh Yoen Kim, Soo Jeong Koh, Yangsoo Jang, Jey Sook Chae, Ji Young Kim, Hyae Jin Kim, Yae Jung Hyun, Jung Rae Cho, Jong Ho Lee.   

Abstract

BACKGROUND: Serum C-reactive protein (CRP) levels, closely associated with cardiovascular disease (CVD) risk are influenced by CRP or interleukin-6 (IL-6) single nucleotide polymorphism (SNPs). However, it is still controversial. Therefore, we investigated the association of IL-6/CRP SNPs and serum CRP levels or other CVD risk factors in healthy adult Korean men.
METHODS: In healthy adult men (age>or=20 years, n=677), we genotyped IL-6-572C>G and CRP SNPs (-717G>A, 1444C>T, 2147A>G) and measured anthropometric parameters, lipid profile, serum levels of CRP and IL-6 and insulin resistance.
RESULTS: At IL-6-572C>G (n=677), subjects with G/G genotype (n=42) showed higher concentrations of CRP (P=0.027) and IL-6 (P=0.028) as compared with C allele carriers after age-adjustment (C/C: n=371, C/G: n=264). Fasting insulin and homeostatis model assessment insulin resistance (HOMA-IR) were also higher in G/G genotype. However, there were no significant differences in other metabolic biomarkers. Among 677 study subjects, 676 were genotyped at CRP-717G>A (G/G: n=513, G/A: n=150, A/A: n=13), 672 at CRP+1444C>T (C/C: n=580, C/T: n=85, T/T: n=7), and 668 at CRP+2147A>G (A/A: n=273, A/G: n=296, G/G: n=99). There were no significant differences in CRP concentrations and other markers related to CVD risk according to each CRP SNP genotype. However, we could find the additive gene-gene interaction between IL-6-572C>G and CRP SNPs on CRP concentration; subjects with the 'G/G' at IL-6-572 showed the highest CRP levels when they have variant allele at CRP SNPs after adjusted for age, body mass index, cigarette smoking and alcohol drinking (-717G>A: F=7.806, P=0.005; CRP+1444C>T: F=8.398, P=0.004; and CRP+2147A>G: F=7.564, P=0.006, respectively) Particularly, G allele carriers at CRP+2147A>G in subjects with IL-6-572G/G showed highest HOMA-IR (F=9.092, P=0.003).
CONCLUSION: The present data showed that serum CRP levels and other CVD risk factors appeared more influenced by IL-6-572C>G rather than CRP SNPs (-717G>A, 1444C>T, and 2147A>G), however CRP levels and insulin resistance may be additively affected by IL-6-572 and CRP SNP, particularly when subjects with G/G genotype at IL-6-572 have allele variant at CRP SNPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17335789     DOI: 10.1016/j.cca.2006.11.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  15 in total

1.  C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.

Authors:  Brandon L Pierce; Mary L Biggs; Marvalyn DeCambre; Alexander P Reiner; Christopher Li; Annette Fitzpatrick; Christopher S Carlson; Janet L Stanford; Melissa A Austin
Journal:  Cancer Causes Control       Date:  2009-03-08       Impact factor: 2.506

Review 2.  Gene-gene, gene-environment, gene-nutrient interactions and single nucleotide polymorphisms of inflammatory cytokines.

Authors:  Amina Nadeem; Sadaf Mumtaz; Abdul Khaliq Naveed; Muhammad Aslam; Arif Siddiqui; Ghulam Mustafa Lodhi; Tausif Ahmad
Journal:  World J Diabetes       Date:  2015-05-15

3.  A functional single-nucleotide polymorphism in interleukin-6 promoter is associated with p wave dispersion in hypertensive subjects with atrial fibrillation.

Authors:  Hai-Hua Geng; Rui Li; Ya-Min Su; Hai-Yan Pan; Min Pan; Xiao-Ping Ji
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Implications of genetic polymorphisms in inflammation-induced atherosclerosis.

Authors:  Jayashree Shanker; Vijay V Kakkar
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

5.  Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families.

Authors:  B Rhodes; A Wong; S V Navarra; C Villamin; T J Vyse
Journal:  Genes Immun       Date:  2008-01-24       Impact factor: 2.676

Review 6.  The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk.

Authors:  Fadi G Hage; Alexander J Szalai
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

7.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

8.  Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension.

Authors:  Jing Li; Jie Song; Min-Hui Jiang; Jin-Guo Zheng; Shu-Ping Gao; Jian-Hua Zhu; Min Pan
Journal:  J Interferon Cytokine Res       Date:  2012-08-27       Impact factor: 2.607

9.  Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach.

Authors:  Benjamin Rhodes; David L Morris; Lakshman Subrahmanyan; Cristin Aubin; Carlos F Mendes de Leon; Jeremiah F Kelly; Dennis A Evans; John C Whittaker; Jorge R Oksenberg; Philip L De Jager; Tim J Vyse
Journal:  Hum Genet       Date:  2008-05-24       Impact factor: 4.132

10.  Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes.

Authors:  J J M Bouwman; R J A Diepersloot; F L J Visseren
Journal:  Clin Vaccine Immunol       Date:  2009-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.